Relypsa, Inc. (RLYP) - NASDAQ
Company Description
Relypsa, Inc. operates as a bio-pharmaceutical company focused on the development and commercialization of non-absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular and metabolic diseases. Its products include patiromer, a non-absorbed for the treatment of... More
Sector: Healthcare
Industry: Biotechnology
Country: United States